Arrowhead Research had a nice pop today and is currently up 7.60% -- which is pretty good. Investors have a more positive outlook for the company and future revenue.
It looks like Arrowhead Research isn't currently at a very decisive point in regards to support/resistance levels. Momentum wise Arrowhead Research, has been oscillating up and down but hasn't shown much directional energy that would be predictive to the near future. ARWR might find some support at the 23.68 level, buyers might push the price back up from here. But it's not very clear what will happen.
The analysts feel pretty optimistic about Arrowhead Research and have been assigning positive ratings. The current Analysts Sentiment Score is 260.31. Most companies range between (-200 to 200).
Here's a break down of the latest rating changes. Bank of America announced that they are initiating coverage with a rating of Buy on 2023-12-04 and added a price target of $29.00. Morgan Stanley announced a lowering of their price target to $37.00 from $40.00 on 2023-11-30. Royal Bank of Canada announced that they are reiterating a rating of Outperform on 2023-11-30 and added a price target of $50.00. Citigroup initiated a rating of Neutral on 2023-09-19 and provided a price target of $33.00. On 2023-08-09 HC Wainwright reiterated their rating of Buy and added a price target of $90.00. On 2023-08-08 there was confirmation of the previous rating by Chardan Capital which was Buy and added a price target of $60.00. Cantor Fitzgerald announced that they are reiterating a rating of Overweight on 2023-08-08 and dropped their 1 year price target to $47.00 which is down from $79.00. TD Cowen initiated a rating of Outperform on 2023-07-21. On 2023-07-20 B. Riley reiterated their rating of Buy and added a price target of $55.00. Piper Sandler gave a boost to their price target and moved to $59.00 from $52.00 on 2023-06-02.
| Company | Ratings Score
?
Composite analyst sentiment score
|
Positive Ratings | Negative Ratings | Boost Price Target | Lower Price Target |
|---|---|---|---|---|---|
| ARWR | 260.31 | 328.12 | -20.03 | 248.81 | -36.27 |
| Company | YOY Growth Score (typical -20 to +20) | Revision Directions (-6 to +6) |
|---|---|---|
| ARWR | -11.61 | -1.31 |
We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.
| Company | Short Score (typical 1-15)
?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
|
Short Interest | Days to Cover | Rate of Change | Shares Short |
|---|---|---|---|---|---|
| ARWR | 7.84 | %7.1 | 7.5 | 13.332 | 7170000 |
| Segment | Count | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest | Analysts Ratings ? |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology | 124 | 0.99 | 0.36 | 12.78 | -8.04 | -13.46 | 4.92 | 58.52 | -26.72 | -29.57 | -31.63 | -27908.47 | -6891.45 | 8.67 | 2.02 | 9.40 | 73.52 |
| Healthcare | 278 | 1.04 | 1.65 | 12.93 | -5.95 | -8.43 | 3.57 | 63.83 | -22.04 | -26.10 | -28.93 | -23997.32 | -7136.36 | 14.66 | 1.98 | 7.06 | 47.18 |
Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.
| Ticker | Social Sentiment(1-10) |
|---|---|
| ARWR |
| Company | Score | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VCYT | Veracyte, Inc. | 1.17 | -1.77 | 1.12 | 10.00 | 3.08 | 1.01 | -10.54 | 69 | -2.64 | -6.86 | -13.97 | -1868.55 | -8613.24 | 0 | 0 | 4.97884 |
| VKTX | Viking Therapeutics, Inc | 1.06 | 15.91 | 28.67 | 44.86 | -4.44 | -37.30 | 253.99 | 71 | -18.45 | -14.95 | -24.83 | -6429.52 | -20399.41 | 0 | 0 | 12.0297 |
| CERS | Cerus Corp | 1.02 | 0.00 | -5.71 | 29.92 | -12.70 | -14.51 | 0.00 | 46 | -30.61 | -38.72 | -83.16 | -1231.93 | -784.63 | 0 | 0 | 4.10401 |
| ADPT | Adaptive Biotechnologies | 0.99 | 1.28 | 8.92 | -0.83 | -23.60 | -38.18 | -46.88 | 56 | -63.49 | -90.14 | -118.40 | -26652.73 | -1840.13 | 0 | 0 | 7.83993 |
| INSM | Insmed, Inc. | 0.99 | 1.70 | 13.32 | 13.13 | 1.77 | 38.59 | 32.40 | 41 | 15.86 | 40.79 | 32.53 | -3903.71 | -10997.44 | 0 | 0 | 9.8069 |
| BEAM | Beam Therapeutics Inc. Co | 0.96 | -0.03 | -0.71 | 26.87 | 13.26 | -13.89 | -36.86 | 72 | -10.07 | -25.36 | -41.80 | -20991.05 | -2640.22 | 0 | 0 | 18.782 |
How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.
